Its results have applications for the private insurance and pharmaceutical sectors as well as the public sector, and it will be of great interest to professionals and researchers in the fields of health economics, economic and healthcare policy-making, and microeconomics. Its primary findings are especially critical to the United States public health sector which is on the cusp of providing a prescription drug benefit to nearly forty million elderly Americans.
The increasing proliferation of copayments is one of the most striking recent developments in the health sector. As debate over their nature and implementation rages on, this volume examines the influence of copayments on the choice of drugs.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
The increasing proliferation of copayments is one of the most striking recent developments in the health sector. As debate over their nature and implementation rages on, this volume examines the influence of copayments on the choice of drugs.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.